Literature DB >> 11393275

Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone.

A P Beelen1, K T Yeo, L D Lewis.   

Abstract

We report a patient who ingested a 2000-mg overdose of quetiapine fumarate (Seroquel). Her maintenance medications also included risperidone, venlafaxine, topiramate, and clonazepam. On presentation, she was drowsy, but had no other significant CNS signs and no cardiac symptoms or abnormal physical signs. Approximately 2 h after the quetiapine ingestion, an electrocardiogram (ECG) showed normal sinus rhythm at 95 beats/min with a corrected QT (QTc) interval of 537 ms (upper limit of normal = 440 ms). Plasma quetiapine concentration at that time was 1800 ng/ml. Continuous ECG monitoring for the subsequent 18 h did not reveal any episode of ventricular tachycardia. A 12-lead ECG 18 h post-overdose was normal with a QTc interval of 401 ms and the corresponding plasma quetiapine concentration was 160 ng/ml. She made an uneventful medical recovery from the toxic ingestion. This case suggests that when patients overdose on quetiapine while taking therapeutic doses of risperidone, such overdoses, even if not massive, can cause considerable QTc interval prolongation. We recommend that quetiapine overdose patients undergo continuous ECG monitoring for 12-18 h post-ingestion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11393275     DOI: 10.1191/096032701678766778

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  9 in total

Review 1.  Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors:  Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  [Lengthening of QT interval by antipsychotic drugs].

Authors:  W Haverkamp; M Deuschle
Journal:  Nervenarzt       Date:  2006-03       Impact factor: 1.214

Review 4.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 5.  A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.

Authors:  Hock Heng Tan; Jason Hoppe; Kennon Heard
Journal:  Am J Emerg Med       Date:  2009-06       Impact factor: 2.469

Review 6.  Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Authors:  Mehrul Hasnain; W Victor R Vieweg; Robert H Howland; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Jules C Hancox; Geneviève C Digby; Adrian Baranchuk; Anand Deshmukh; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2014-06

Review 7.  Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Jules C Hancox; Adrian Baranchuk; Geneviève C Digby; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Anand Deshmukh; Ananda K Pandurangi
Journal:  Psychopharmacology (Berl)       Date:  2013-06-30       Impact factor: 4.530

Review 8.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

9.  New Generation Antipsychotic Drugs and QTc Interval Prolongation.

Authors:  W VictorR Vieweg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.